Painreform Stock Performance
| PRFX Stock | USD 0.83 0.03 3.49% |
The company holds a Beta of 2.6, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Painreform will likely underperform. At this point, Painreform has a negative expected return of -0.72%. Please make sure to check Painreform's standard deviation, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Painreform performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Painreform has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain fairly strong which may send shares a bit higher in January 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Last Split Factor 1:6 | Last Split Date 2024-09-09 |
1 | What momentum shifts mean for PainReform Ltd. - Weekly Stock Analysis Weekly Setup with High ROI Potential - newser.com | 10/21/2025 |
2 | Best data tools to analyze PainReform Ltd. stock - 2025 AllTime Highs Safe Entry Point Alerts - newser.com | 10/30/2025 |
3 | Is PainReform Ltd. stock cheap at current valuation - July 2025 Reactions Consistent Income Trade Recommendations - newser.com | 11/04/2025 |
4 | PainReform Ltd. Stock Price Live Quotes Charts NSC - StocksToTrade | 11/10/2025 |
5 | PainReform schedules annual shareholder meeting for December 30 in Tel Aviv - Investing.com | 11/25/2025 |
6 | PainReform Commences Development for OcuRing-K Phase II Trial, LayerBios Drop-Less Sustained-Release Ocular Therapy | 12/02/2025 |
7 | PainReform Confirms the Ability of Its LayerBio Drop-Less Sustained-Release Ocular Platform to Accommodate Multiple Drug Entities | 12/10/2025 |
| Begin Period Cash Flow | 8 M | |
| Total Cashflows From Investing Activities | -13 K |
Painreform | Build AI portfolio with Painreform Stock |
Painreform Relative Risk vs. Return Landscape
If you would invest 142.00 in Painreform on September 29, 2025 and sell it today you would lose (59.00) from holding Painreform or give up 41.55% of portfolio value over 90 days. Painreform is currently does not generate positive expected returns and assumes 4.7454% risk (volatility on return distribution) over the 90 days horizon. In different words, 42% of stocks are less volatile than Painreform, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Painreform Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Painreform's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Painreform, and traders can use it to determine the average amount a Painreform's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1527
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PRFX |
Based on monthly moving average Painreform is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Painreform by adding Painreform to a well-diversified portfolio.
Painreform Fundamentals Growth
Painreform Stock prices reflect investors' perceptions of the future prospects and financial health of Painreform, and Painreform fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Painreform Stock performance.
| Return On Equity | -1.28 | ||||
| Return On Asset | -0.36 | ||||
| Current Valuation | (183.06 K) | ||||
| Shares Outstanding | 2.01 M | ||||
| Price To Book | 0.38 X | ||||
| EBITDA | (14.55 M) | ||||
| Net Income | (14.59 M) | ||||
| Cash And Equivalents | 13.85 M | ||||
| Cash Per Share | 1.30 X | ||||
| Total Debt | 45 K | ||||
| Current Ratio | 29.02 X | ||||
| Book Value Per Share | 4.19 X | ||||
| Cash Flow From Operations | (12.62 M) | ||||
| Earnings Per Share | 29.90 X | ||||
| Market Capitalization | 1.87 M | ||||
| Total Asset | 4.53 M | ||||
| Retained Earnings | (56.45 M) | ||||
| Working Capital | 1.99 M | ||||
About Painreform Performance
Evaluating Painreform's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Painreform has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Painreform has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 171.3 K | 179.9 K | |
| Return On Tangible Assets | (3.22) | (3.39) | |
| Return On Capital Employed | (7.04) | (6.69) | |
| Return On Assets | (3.22) | (3.39) | |
| Return On Equity | (8.00) | (7.60) |
Things to note about Painreform performance evaluation
Checking the ongoing alerts about Painreform for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Painreform help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Painreform generated a negative expected return over the last 90 days | |
| Painreform has some characteristics of a very speculative penny stock | |
| Painreform has high historical volatility and very poor performance | |
| Painreform has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (14.59 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Painreform currently holds about 13.85 M in cash with (12.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.3, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Painreform has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: PainReform Confirms the Ability of Its LayerBio Drop-Less Sustained-Release Ocular Platform to Accommodate Multiple Drug Entities |
- Analyzing Painreform's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Painreform's stock is overvalued or undervalued compared to its peers.
- Examining Painreform's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Painreform's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Painreform's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Painreform's stock. These opinions can provide insight into Painreform's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Painreform Stock Analysis
When running Painreform's price analysis, check to measure Painreform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Painreform is operating at the current time. Most of Painreform's value examination focuses on studying past and present price action to predict the probability of Painreform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Painreform's price. Additionally, you may evaluate how the addition of Painreform to your portfolios can decrease your overall portfolio volatility.